4AB:FRA
AbbVie Common Stock
233,10 €
arrow_upward
+1,30%(+3,00) 1D
2-окт., 22:00:00 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
230,00 €
High
233,10 €
Low
230,00 €
Mkt. cap
464,43 млд
Avg. vol.
47,00
Volume
5,00
52-wk high
235,70 €
52-wk low
167,55 €
No. of employees
57 миң
Open
230,00 €
High
233,10 €
Low
230,00 €
Mkt. cap
464,43 млд
Avg. vol.
47,00
Volume
5,00
52-wk high
235,70 €
52-wk low
167,55 €
No. of employees
57 миң
News stories
From web sources and news partners
MarketWatch
·
9 саат мурун
AbbVie Inc. stock outperforms competitors on strong trading day
TipRanks
·
13 саат мурун
AbbVie’s Venetoclax AML Study in Greece: What the Latest Update Means for Investors
The Globe and Mail
·
18 саат мурун
AbbVie (ABBV) Receives a Buy from Scotiabank
The Motley Fool
·
1 күн мурун
AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57 миң
Founded2012-ж., 10-апр.
HeadquartersСевер Чикаго, Иллинойс, Америка Кошмо Штаттары
Sector-
Websiteabbvie.com